Corporate ActionSep 24, 2026, 05:20 PM
Glucotrack Prices $3.1M Stock and Warrant Offering
AI Summary
Glucotrack, Inc. announced the pricing of a registered direct offering of common stock and pre-funded warrants, aiming to raise approximately $3.1 million in gross proceeds. The funds will be allocated towards repaying existing debt and bolstering working capital and general corporate needs. Dawson James Securities, Inc. served as the sole placement agent. As part of the agreement, the company's directors and executive officers have committed to 90-day lock-up periods.
Key Highlights
- Glucotrack, Inc. priced a registered direct offering of 169,388 shares of common stock and pre-funded warrants.
- The offering is expected to raise approximately $3.1 million in gross proceeds.
- Net proceeds will be used to pay off existing debt and for working capital and general corporate purposes.
- The offering includes pre-funded warrants to purchase up to 1,350,220 shares of common stock.
- Dawson James Securities, Inc. acted as the sole placement agent for the offering.
- Company directors and executive officers entered into 90-day lock-up agreements.
Price Impact
More from GCTK